
|Articles|April 6, 2007
New OAB therapies are on the way
With seven approved drugs for overactive bladder already on the market, the potential for new treatments might seem to be limited. The reality is that OAB treatment is still not optimal.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Experts urge FDA to revisit labeling for testosterone replacement therapy in men
2
Sildenafil cream for female sexual arousal disorder available to prescribe in select states
3
FDA approves first-line Zenflow system for the treatment of BPH
4
FDA approves gepotidacin for uncomplicated urogenital gonorrhea
5
















